XML 43 R33.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Note 1 - Organization (Details Textual)
3 Months Ended 6 Months Ended
Sep. 30, 2023
shares
Sep. 22, 2023
shares
Jul. 12, 2021
shares
Jun. 30, 2024
USD ($)
Jun. 30, 2024
USD ($)
Apr. 22, 2024
shares
Sep. 21, 2023
Number of Limited Liability Companies       2 2    
Number of Limited Partnerships in which Company is Sole General Partner       5      
Long-Term Debt, Maturity, Year One | $       $ 38,170,386 $ 38,170,386    
Common Class A [Member]              
Stock Issued During Period, Shares, New Issues (in shares)     1,000,000        
Conduit Pharmaceuticals Inc [Member]              
Stock Issued During Period, Shares, New Issues (in shares)   754,000          
Stock Issued During Period, Shares, Acquisitions (in shares)   65,000,000          
Conduit Pharmaceuticals Inc [Member] | Director [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) 45,000 45,000          
Stock Issued During Period, Shares, Issued for Services (in shares) 45,000 45,000          
Conduit Pharmaceuticals Inc [Member] | Private Warrants [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)   754,000       540,000  
Conduit Pharmaceuticals Inc [Member] | Private Warrants [Member] | Common Class A [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)   754,000          
Conduit Pharmaceuticals Inc [Member] | Conversion of Class B to Class A Common Stock [Member]              
Stock Issued During Period, Shares, Conversion of Convertible Securities (in shares)   3,306,250          
Murphy Canyon Acquisition Sponsor, LLC (SPAC) [Member] | Private Warrants [Member] | Common Class A [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares)   754,000          
Special Purpose Acquisition Company (SPAC) [Member]              
Subsidiary, Ownership Percentage, Parent             65.00%
Conduit Pharmaceuticals Inc [Member]              
Investment Owned, Net Assets, Percentage 6.50% 6.50%   6.30% 6.30%    
Mortgage Notes [Member]              
Long-Term Debt, Maturity, Year One | $       $ 12,500,000 $ 12,500,000    
Model Home Properties [Member]              
Number of Limited Partnerships in which Company is Sole General Partner         6    
Commercial Property [Member]              
Number of Real Estate Properties, Fee Simple       12 12    
Commercial Property [Member] | Partially Owned Properties [Member]              
Number of Real Estate Properties, Fee Simple       2 2    
Model Home Properties [Member] | Mortgage Notes [Member]              
Long-Term Debt, Maturity, Year One | $       $ 2,900,000 $ 2,900,000